Don Frail (Past Speaker)

Don joined Allergan in 2014 and leads the Research, Clinical Pharmacology, Toxicology, and ADME efforts for the organization and the External Science & Innovation efforts that partner with Business Development to evaluate and implement partnerships, licensing, and acquisitions across all therapeutic areas. With over twenty years of pharmaceutical and academia research and management experience Don has been involved in a variety of pre-clinical drug discovery and Ph1/Ph2 clinical research areas and environments, including the entry of more than 25 compounds into development across therapeutic areas. Previous roles included heading the Emerging Innovations Unit at AstraZeneca, the Indications Discovery Units at Pfizer, the CNS Discovery organization at Pharmacia.